2019 revenue up 10.3% for theranostics and up 6.4% for IVD Continued improvement in operating income and net income before non-recurring items Positive net income partly driven by non-recurring instrumentation sales. Profits reinvested in development…
Croissy-Beaubourg, March 9, 2020, 6:00 pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has CE marked the first four i-Tracker® test kits…
Croissy-Beaubourg, February 19, 2020, 5:45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, has been actively involved in the establishment and validation of a new World Health…